Skip NavigationSkip to Content

Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control

  1. Author:
    Rosen, Brandon C
    Sawatzki, Kaitlin
    Ricciardi, Michael J
    Smith, Elise
    Golez, Inah
    Mauter, Jack T
    Pedreño-López, Núria
    Yrizarry-Medina, Aaron
    Weisgrau, Kim L
    Vosler, Logan J
    Voigt, Thomas B
    Louw, Johan J
    Tisoncik-Go, Jennifer
    Whitmore, Leanne S
    Panayiotou, Christakis
    Ghosh, Noor
    Furlott, Jessica R
    Parks, Christopher L
    Desrosiers, Ronald C
    Lifson,Jeffrey
    Rakasz, Eva G
    Watkins, David I
    Gale, Michael
  2. Author Address

    Department of Pathology, George Washington University School of Medicine and Health Sciences, Washington, DC, United States., Department of Immunology, Center for Innate Immunity and Immune Disease, School of Medicine, University of Washington, Seattle, WA, United States., Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States., International AIDS Vaccine Initiative, New York, NY, United States., Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, United States., AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.,
    1. Year: 2024
    2. Epub Date: 2024 10 22
  1. Journal: Frontiers in Immunology
    1. 15
    2. Pages: 1478063
  2. Type of Article: Article
  3. Article Number: 1478063
  1. Abstract:

    Spontaneous control of chronic-phase HIV/SIV viremia is often associated with the expression of specific MHC class I allotypes. HIV/SIV-specific CD8+ cytotoxic T lymphocytes (CTLs) restricted by these MHC class I allotypes appear to be critical for viremic control. Establishment of the elite controller (EC) phenotype is predictable in SIVmac239-infected Indian rhesus macaques (RMs), with approximately 50% of Mamu-B*08+ RMs and 20% of Mamu-B*17+ RMs becoming ECs. Despite extensive characterization of EC-associated CTLs in HIV/SIV-infected individuals, the precise mechanistic basis of elite control remains unknown. Because EC and non-EC viral load trajectories begin diverging by day 14 post-infection, we hypothesized that hyperacute innate immune responses may contribute to viremic control. To gain insight into the immunological factors involved in the determination of EC status, we vaccinated 16 Mamu-B*08+ RMs with Vif and Nef to elicit EC-associated CTLs, then subjected these 16 vaccinees and an additional 16 unvaccinated Mamu-B*08+ controls to repeated intrarectal SIVmac239 challenges. We then performed whole-blood transcriptomic analysis of all 32 SIVmac239-infected Mamu-B*08+ RMs and eight SIVmac239-infected Mamu-B*08- RMs during the first 14 days of infection. Vaccination did not provide protection against acquisition, but peak and setpoint viremia were significantly lower in vaccinees relative to controls. We did not identify any meaningful correlations between vaccine-induced CTL parameters and SIVmac239 acquisition rate or chronic-phase viral loads. Ultimately, 13 of 16 vaccinees (81%) and 7 of 16 controls (44%) became ECs (viremia = 10,000 vRNA copies/mL plasma for = 4 weeks). We identified subsets of immunomodulatory genes differentially expressed (DE) between RM groupings based on vaccination status, EC status, and MHC class I genotype. These DE genes function in multiple innate immune processes, including the complement system, cytokine/chemokine signaling, pattern recognition receptors, and interferon-mediated responses. A striking difference in the kinetics of differential gene expression among our RM groups suggests that Mamu-B*08-associated elite control is characterized by a robust, rapid innate immune response that quickly resolves. These findings indicate that, despite the association between MHC class I genotype and elite control, innate immune factors in hyperacute SIV infection preceding CTL response development may facilitate the establishment of the EC phenotype. Copyright © 2024 Rosen, Sawatzki, Ricciardi, Smith, Golez, Mauter, Pedreño-López, Yrizarry-Medina, Weisgrau, Vosler, Voigt, Louw, Tisoncik-Go, Whitmore, Panayiotou, Ghosh, Furlott, Parks, Desrosiers, Lifson, Rakasz, Watkins and Gale.

    See More

External Sources

  1. DOI: 10.3389/fimmu.2024.1478063
  2. PMID: 39502699
  3. PMCID: PMC11534762

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel